Arthur S. Kirsch, Director at Aralez Pharmaceuticals Inc. (ARLZ), bought 45,000 shares at $2.27 ($102K) on 2017-03-15, disclosed to the SEC on 2017-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| LQDA | BUY | 2021-11-12 | $127K | — | Filing → |
| LQDA | BUY | 2018-11-15 | $18K | — | Filing → |
| LQDA | BUY | 2018-11-13 | $18K | — | Filing → |